Trial Profile
Clinical Trials Insight: 700034311
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2008
Price :
$35
*
At a glance
- Drugs Amikacin (Primary)
- Indications Gram-negative infections; Ventilator associated pneumonia
- Focus Pharmacokinetics
- Sponsors Bayer HealthCare Pharmaceuticals Inc.; Nektar Therapeutics
- 09 Jun 2008 New trial record.